TELA Bio (TELA) Enterprise Value (2018 - 2026)

TELA Bio's Enterprise Value history runs 9 years deep, the most recent figure standing at -$39.5 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 7.69% year-over-year to -$39.5 million; the TTM figure through Mar 2026 stood at -$39.5 million (up 7.69% YoY), while the FY2025 annual figure was -$50.8 million, up 3.46% from the prior year.
• Enterprise Value was -$39.5 million for Q1 2026 at TELA Bio, up from -$50.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$17.3 million in Q3 2024 to a low of -$65.3 million in Q2 2023.
• Historically, Enterprise Value has averaged -$40.5 million across 5 years, with a median of -$39.5 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value sank 135.4% in 2023, then jumped 70.27% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$42.0 million in 2022, then dropped by 11.21% to -$46.7 million in 2023, then dropped by 12.71% to -$52.7 million in 2024, then rose by 3.46% to -$50.8 million in 2025, then climbed by 22.23% to -$39.5 million in 2026.
• The last three Enterprise Value figures came in at -$39.5 million (Q1 2026), -$50.8 million (Q4 2025), and -$29.7 million (Q3 2025), per Business Quant data.